Skip to content
Home/Companies/Healthcare/Brosmed

Brosmed

Healthcare·China·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Brosmed?

Brosmed is currently owned by Cathay Capital through Cathay Capital Small Cap III (2016 vintage), since 2020.

Hand-verified · updated 2026-04-21

Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap III · 2016 · Growth

Key facts

HQChina
SectorHealthcare

More from Cathay Capital Small Cap III

Other portfolio companies in the same fund.

Aukey
Aukey
Active
ConsumerChina· 2020
Biose Industrie
Biose Industrie
Exited 2024
HealthcareFrance· 2020
to
Deerma
Deerma
Active
ConsumerChina· 2020
EasyVista
EasyVista
Active
SoftwareFrance· 2020
Fapon
Active
HealthcareChina· 2020
FuturMaster
FuturMaster
Active
SoftwareFrance· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Brosmed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Brosmed?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Brosmed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue